Notoginsenoside R1 Regulates Ischemic Myocardial Lipid Metabolism by Activating the AKT/mTOR Signaling Pathway

Ischemic heart diseases are responsible for more than one-third of all deaths worldwide. Radix notoginseng is widely used to treat ischemic heart disease in China and other Asian countries, and notoginsenoside R1 (NGR1) is its characteristic and large-amount ingredient. However, the potential molecu...

Full description

Bibliographic Details

Published in:	Frontiers in Pharmacology
Main Authors:	Wei Lei, Yiqi Yan, Yaolei Ma, Min Jiang, Boli Zhang, Han Zhang, Yuhong Li
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-06-01
Subjects:	notoginsenoside R1 ischemic heart disease cardio-protection lipid metabolism Akt/mTOR pathway
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2022.905092/full